Aurinia Pharmaceuticals (AUPH) Tax Provisions (2020 - 2026)
Aurinia Pharmaceuticals (AUPH) posted Tax Provisions of $9.6 million for Q1 2026, up 105.47% on a QoQ basis from -$175.1 million in Q4 2025, and up 852.24% year-over-year from $1.0 million in Q1 2025.
Aurinia Pharmaceuticals (AUPH) Tax Provisions (2020 - 2026) Analysis & Trends
Aurinia Pharmaceuticals' Tax Provisions history runs 7 years deep, the most recent figure standing at $9.6 million for Q1 2026.
- Quarterly Tax Provisions rose 852.24% year-over-year to $9.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$164.5 million (down 8507.46% YoY) and the FY2025 annual result came in at -$173.0 million, down 10303.12% from the prior year.
- Tax Provisions was $9.6 million for Q1 2026 at Aurinia Pharmaceuticals, up from -$175.1 million in the prior quarter.
- Across five years, Tax Provisions topped out at $9.6 million in Q1 2026 and bottomed at -$175.1 million in Q4 2025.
- A 5-year average of -$9.4 million and a median of $451000.0 in 2023 frame the typical range for Tax Provisions.
- Annual changes were most pronounced in 2022 — Tax Provisions soared 11825.0% — and 2025, when it plunged 57500.0%.
- Aurinia Pharmaceuticals' Tax Provisions stood at $827000.0 in 2022, then plunged by 45.47% to $451000.0 in 2023, then plunged by 167.41% to -$304000.0 in 2024, then plunged by 57500.0% to -$175.1 million in 2025, then soared by 105.47% to $9.6 million in 2026.
- Business Quant data shows AUPH's Tax Provisions at $9.6 million in Q1 2026, -$175.1 million in Q4 2025, and $400000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 31.86 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 188,883.60 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 179.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Aurinia Pharmaceuticals | 2.02 Bn | 1.64 Bn | 71.20 Mn | 9.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.57 Mn |
| Dec 31, 2025 | -175.10 Mn |
| Sep 30, 2025 | 400,000.00 |
| Jun 30, 2025 | 600,000.00 |
| Mar 31, 2025 | 1.01 Mn |
| Dec 31, 2024 | -304,000.00 |
| Sep 30, 2024 | 500,000.00 |
| Jun 30, 2024 | 756,000.00 |
| Mar 31, 2024 | 700,000.00 |
| Dec 31, 2023 | 451,000.00 |
| Sep 30, 2023 | 300,000.00 |
| Jun 30, 2023 | -642,000.00 |
| Mar 31, 2023 | 436,000.00 |
| Dec 31, 2022 | 827,000.00 |
| Sep 30, 2022 | 954,000.00 |
| Jun 30, 2022 | 9,000.00 |
| Mar 31, 2022 | 10,000.00 |
| Dec 31, 2021 | 726,000.00 |
| Sep 30, 2021 | 8,000.00 |
| Jun 30, 2021 | 18,000.00 |